SlideShare a Scribd company logo
1 of 69

Vasculitides constitute a
spectrum of diseases
characterized by inflammation
& necrosis of blood vessels with
resulting ischemia of those
tissues supplied by the affected
vessels. These are rare diseases
& have late diagnosis.

CLASSIFICATION
depending on the size
of the affected blood
vessel:

1- large vessel
vasculitis:

-Takayasu's arteritis

- Giant cell
arteritis(Polymyalgia rheumatica)

- Aortitis associated with
an underlying inflammatory
diseases such as
spondyloarthropathy

2- medium vessel vasculitis:

- polyarteritis
nodosa.

-Churg- Strauss
syndrome

- Kawasaki disease

3- small vessel vasculitis :

- Wegener's granulomatosis

- Henoch Schonlein purpura

-Leukocytoclastic vasculitis

-Cryptoglobulinemic
vasculitis

-vasculitis associated with
connective tissue diseases.

Clinical classification of
vasculitis: :

1- purpuric disorders=
HSP, leukocytic vasculitis

2- microscopic
polyarteritis=
polyarteritis nodosa

3- aortic type= Takayosu
disease, polyarteritis nodosa(in
the latter, the subclavian artery
is spared ).

4- pulmonary type= Wegener's
granulomatous, Churg- Strauss
syndrome
GIANT CELL ARTERITIS(GCA)/
POLYMYALGIA RHEUMATICA

GCA also called temporal
arteritis or cranial arteritis &
this is the most common type
of systemic vasculitis.
GIANT CELL ARTERITIS(GCA)/
POLYMYALGIA RHEUMATICA

It especially involve
branches of carotid artery
of patients over the age of
50, often female patients.

C/F : headache not
responding to analgesia, scalp
tenderness, visual
disturbances, jaw
claudication, arthralgia&
monocular blindness which is
irreversible. 90% of patients
have high ESR.

Biopsy of a segment of
temporal artery; reveals
characteristic findings of
inflammation &
destruction of internal
elastic lamina with
GIANT cells present.
POLYMYALGIA RHEUMATICA(PMR)

Characterized by pain , stiffness
of shoulders & hip girdles &
proximal extremities. It also
associated with high ESR&
anemia.

It commonly occurs in female
over 50 years.

Diagnosis is made on clinical
grounds& rapid response to
steroids.

PMR& GCA are likely part of
same disease spectrum & some
patients may have symptoms of
both diseases.

In GCA, corticosteroids
treatment is obligatory
because they significantly
reduce the irreversible visual
loss and other focal ischemic
lesions, but much higher
doses are needed than in
PMR.

Treatment should not
be delayed, especially if
there have already been
episodes of visual loss
or stroke.


Starting doses of prednisolone
are:-

PMR: 10-15 mg as a single dose
in the morning.

GCA: 60-100 mg, usually in
divided doses.

The dose should be reduced
gradually in weekly or monthly
steps.

Calcium and vitamin D
supplement and sometimes
bisphosphonates are necessarily
needed to prevent osteoporosis
while high dose of steroids are
given. In PMR, the response
appears in a matter of few days.

The outcome of both
disease is excellent , but
relapse may occur
during treatment or
years after cessation of
treatment.

TAKAYASU'S ARTERITIS is
a large vessel disease that
affect young female but can
be seen in both male &
female up to the age of 50. It
also known as pulse less
disease.

TA results in stenosis of aorta &
its branches like cerebral ,
brachiocephalic, renal ,
mesenteric , femoral & coronary
arteries.

Stenosis of proximal aorta& its
proximal branches is the most
common finding.

Clinically limb claudication ,
lightheadedness, malaise, fever
& arthralgia , all are
experienced by such patients.
There was a delay in diagnosis
for years even if the stenosis is
sever because most patients are
asymptomatic.

Diagnosis is made by
angiography. Treatment
includes chronic steroids. Some
patients may respond to
immunosuppressive drugs like
methotrexate&
cyclophosphamide. Some
patients require corrective
vascular angioplasty.

POLYARTERITIS
NODOSA(PAN) is a medium
vessel inflammatory vasculitis
involving segmental necrotizing
lesions often at arterial branch
points leading to stenosis,
thrombosis, hemorrhage or
infarction of the involved artery.

Classical PAN is rare condition
which, unlike other vasculitic
diseases, usually occurs in middle-
age men. It is accompanied by sever
systemic manifestations, and its
occasional association with
hepatitis B antigenaemia suggest a
vasculitis secondary to the
deposition of immune complexes.

Pathologically, there is
fibrinoid necrosis of
vessel walls with
microaneurysm
formation, thrombosis
and infarction.
CLINICAL FEATURES::

These include fever,
malaise, weight loss and
myalgia. These initial
symptoms are fallowed by
dramatic acute features
that are due to organs
infarction.

* Neurological features-
mononeuritis multiplex

* Abdominal pain due to arterial
involvement of abdominal viscera,
mimicking acute cholecystitis,
pancreatitis and appendicitis.

* Renal- presents with hematuria
and proteinuria. Hypertension and
acute /chronic renal failure occur.

* Cardiac- Coronary arteritis
causes myocardial infarction
and heart failure.

* Skin –subcutaneous
hemorrhage and gangrene
occur.

* Lung involvement is rare.
INVESTIGATIONS::

-blood count. Anemia, leukocytosis
and high ESR.

* biopsy of involved artery.

-angiography. Demonstrate
microaneurysms in hepatic,
intestinal or renal vessels.

Most patients are undiagnosed
until postoperatively for ischemic
events.
TREATMENT::-

Corticosteroid usually in
combination with
immunosuppressive drugs such
as azathioprine. The use of
antiviral drugs in patients with
positive serology of hepatitis
B&C is promising.

Churg-Strauss syndrome also
known as allergic
granulomatosis& agiitis& this is
a medium & small vessel
vasculitis that has extravascular
manifestations which can
distinguish it from other types
of vasculitis.

The typical presentation is a
middle age person with
chronic asthma who develops
pulmonary infiltrates,
vasculitis& eosinophilia. The
vasculitis involves the skin,
peripheral nerves& GIT, but
other organs may be affected.

Biopsy shows
microgranulomas& eosinophilic
deposits. The pulmonary
infiltrates are patchy but rapidly
resolve with steroid treatment.

Recent reports showed that anti-
leukotriene drugs used in
treatment of asthma may cause
CSS.

Diagnosis is made depending on
clinical findings but biopsy is often
needed. Eosinophilia is present in
almost all patients but rapidly
returns to normal on giving
steroids. Anti-neuotrophil
cytoplasmic auto antibodies(P-
ANCA) are positive in most
patients.

Treatment is based on
steroids, but
immunosuppressive drugs
may be needed in some
patients. The prognosis is
fairly good but relapse rate is
common.

WEGENER'S GRANULOMATOSIS(WG)

small& medium vessel vasculitis with
many extra vascular manifestations.
Although any anatomic area can be
affected, the three most common sites
of involvement are : the sinuses&
upper airways, the lungs, & the
kidneys.
Face
Involvement

The patients may only
diagnosed after months or years
of subtle symptoms. However
WG can be presented with
alveolar hemorrhage & or
rapidly progressive GN, both of
which account for much of the
mortality from the disease.

Destruction of nasal sinus
tissues may result in facial
deformities. Pseudo tumor
can occur everywhere but
commonly in lungs & retro
orbital spaces. Skin ,
peripheral nerves & eye
involvement are common.

Diagnosis is made on tissue
biopsy. ANCA of C-
ANCA(cytoplasmic) is positive
in 90% of patients with renal
disease&70% without renal
disease. P-ANCA also can be
found.

The mortality of untreated WG
approaches 100%.

Treatment is steroids, but this is
inadequate. Therefore
combination with
immunosuppressive drugs
cyclophosphamide &
methotrexate is helpful. Relapse
is common.
HENOCH SCHONLEIN PURPURA(HSP)

is a small vessel vasculitis
affecting children & young
adults. Classical clinical triad
of palpable purpura at
buttocks, arthritis&
abdominal pain is found in
80% of patients.
HENOCH SCHONLEIN PURPURA(HSP)

Fever & glomerulonephritis are
also common. Affected vessels have
IG &complement deposition&
serum IgA is often elevated. IgA
deposition in renal lesions is
characteristic. Diagnosis is
confirmed depending on clinical &
laboratory findings.

Although patients with HSP
may develop bowel
perforation or significant
renal disease, the majority
improve without sequelae.
Most patients improve within
weeks or months.

Ddx: drug induced purpura, SLE,
gonococcal arthralgia, keratoderma
blennorhagica& secondary syphilis.

Treatment is supportive with NSAIDs
& analgesia.

Steroids are kept for more symptomatic
patients. Those with chronic renal
diseases require steroids &
immunosuppressive drugs.

***********
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx

More Related Content

Similar to D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx

Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)Viju Rathod
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)student
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisAzfahsyaRafifYusro
 
VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION Neetu Ojha
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptxfarahalamleh
 
Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Marwa Besar
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptxBVDUPathology1
 
Approach to a patient with vasculitis
Approach to a patient with vasculitisApproach to a patient with vasculitis
Approach to a patient with vasculitisaminanurnova
 
Pulmonary Renal Syndromes
Pulmonary Renal SyndromesPulmonary Renal Syndromes
Pulmonary Renal SyndromesZunaira Islam
 
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...Rohit Rajeevan
 

Similar to D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx (20)

Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)
 
VASCULITIS.pdf
VASCULITIS.pdfVASCULITIS.pdf
VASCULITIS.pdf
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION VASCULITIS- CASE PRESENTATION
VASCULITIS- CASE PRESENTATION
 
Vasculitis only
Vasculitis onlyVasculitis only
Vasculitis only
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptx
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
THE VASCULITIS SYNDROME
THE VASCULITIS SYNDROMETHE VASCULITIS SYNDROME
THE VASCULITIS SYNDROME
 
THE VASCULITIS SYNDROME
THE VASCULITIS SYNDROMETHE VASCULITIS SYNDROME
THE VASCULITIS SYNDROME
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptx
 
Approach to a patient with vasculitis
Approach to a patient with vasculitisApproach to a patient with vasculitis
Approach to a patient with vasculitis
 
VASCULITIS AND UPDATES
VASCULITIS  AND UPDATESVASCULITIS  AND UPDATES
VASCULITIS AND UPDATES
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Pulmonary Renal Syndromes
Pulmonary Renal SyndromesPulmonary Renal Syndromes
Pulmonary Renal Syndromes
 
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
 

More from hussainAltaher

طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptx
طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptxطلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptx
طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptxhussainAltaher
 
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptx
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptxD. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptx
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptxhussainAltaher
 
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxد. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxhussainAltaher
 
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxد. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxhussainAltaher
 
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytr
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytrPPH-6 (Muhadharaty).pptx , tyuiop[oiuytr
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytrhussainAltaher
 
4- LUNG ABSCESS &EMPYEMA (2)...............pptx
4- LUNG ABSCESS &EMPYEMA (2)...............pptx4- LUNG ABSCESS &EMPYEMA (2)...............pptx
4- LUNG ABSCESS &EMPYEMA (2)...............pptxhussainAltaher
 
endometrial cancer #.ppt.......................
endometrial cancer #.ppt.......................endometrial cancer #.ppt.......................
endometrial cancer #.ppt.......................hussainAltaher
 
Assisted RT22.ppt.......................
Assisted RT22.ppt.......................Assisted RT22.ppt.......................
Assisted RT22.ppt.......................hussainAltaher
 
4- LUNG ABSCESS &EMPYEMA (2).........pptx
4- LUNG ABSCESS &EMPYEMA (2).........pptx4- LUNG ABSCESS &EMPYEMA (2).........pptx
4- LUNG ABSCESS &EMPYEMA (2).........pptxhussainAltaher
 
Chest Trauma (2).pptx....................
Chest Trauma (2).pptx....................Chest Trauma (2).pptx....................
Chest Trauma (2).pptx....................hussainAltaher
 
congnital anomaly (2).pptx..............
congnital anomaly (2).pptx..............congnital anomaly (2).pptx..............
congnital anomaly (2).pptx..............hussainAltaher
 
BURN.pptx.............general ............
BURN.pptx.............general ............BURN.pptx.............general ............
BURN.pptx.............general ............hussainAltaher
 
5- BRONCHIACTASIS..pptx thoracic surgery
5- BRONCHIACTASIS..pptx thoracic surgery5- BRONCHIACTASIS..pptx thoracic surgery
5- BRONCHIACTASIS..pptx thoracic surgeryhussainAltaher
 
Soft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptxSoft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptxhussainAltaher
 
Princile of aesthetic sugery. General surgerypptx
Princile of aesthetic sugery. General surgerypptxPrincile of aesthetic sugery. General surgerypptx
Princile of aesthetic sugery. General surgerypptxhussainAltaher
 
PERIOPERATIVE FLUID THERAPY 22222023.ppt
PERIOPERATIVE FLUID THERAPY 22222023.pptPERIOPERATIVE FLUID THERAPY 22222023.ppt
PERIOPERATIVE FLUID THERAPY 22222023.ppthussainAltaher
 
D. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty requireD. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty requirehussainAltaher
 
100-Mcqs-In-Neonatology.ppt
100-Mcqs-In-Neonatology.ppt100-Mcqs-In-Neonatology.ppt
100-Mcqs-In-Neonatology.ppthussainAltaher
 

More from hussainAltaher (20)

طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptx
طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptxطلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptx
طلاب كروب D Osce slides in gynaecology-1 (Muhadharaty).pptx
 
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptx
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptxD. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptx
D. Ihsan Rotator Cuff Disorders-4 (Muhadharaty).pptx
 
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxد. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
 
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptxد. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
د. عمار الياسري shoulder and pectoral girdle-5 (Muhadharaty).pptx
 
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytr
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytrPPH-6 (Muhadharaty).pptx , tyuiop[oiuytr
PPH-6 (Muhadharaty).pptx , tyuiop[oiuytr
 
4- LUNG ABSCESS &EMPYEMA (2)...............pptx
4- LUNG ABSCESS &EMPYEMA (2)...............pptx4- LUNG ABSCESS &EMPYEMA (2)...............pptx
4- LUNG ABSCESS &EMPYEMA (2)...............pptx
 
endometrial cancer #.ppt.......................
endometrial cancer #.ppt.......................endometrial cancer #.ppt.......................
endometrial cancer #.ppt.......................
 
Assisted RT22.ppt.......................
Assisted RT22.ppt.......................Assisted RT22.ppt.......................
Assisted RT22.ppt.......................
 
4- LUNG ABSCESS &EMPYEMA (2).........pptx
4- LUNG ABSCESS &EMPYEMA (2).........pptx4- LUNG ABSCESS &EMPYEMA (2).........pptx
4- LUNG ABSCESS &EMPYEMA (2).........pptx
 
Chest Trauma (2).pptx....................
Chest Trauma (2).pptx....................Chest Trauma (2).pptx....................
Chest Trauma (2).pptx....................
 
congnital anomaly (2).pptx..............
congnital anomaly (2).pptx..............congnital anomaly (2).pptx..............
congnital anomaly (2).pptx..............
 
BURN.pptx.............general ............
BURN.pptx.............general ............BURN.pptx.............general ............
BURN.pptx.............general ............
 
5- BRONCHIACTASIS..pptx thoracic surgery
5- BRONCHIACTASIS..pptx thoracic surgery5- BRONCHIACTASIS..pptx thoracic surgery
5- BRONCHIACTASIS..pptx thoracic surgery
 
Soft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptxSoft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptx
 
Princile of aesthetic sugery. General surgerypptx
Princile of aesthetic sugery. General surgerypptxPrincile of aesthetic sugery. General surgerypptx
Princile of aesthetic sugery. General surgerypptx
 
PERIOPERATIVE FLUID THERAPY 22222023.ppt
PERIOPERATIVE FLUID THERAPY 22222023.pptPERIOPERATIVE FLUID THERAPY 22222023.ppt
PERIOPERATIVE FLUID THERAPY 22222023.ppt
 
D. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty requireD. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty require
 
100-Mcqs-In-Neonatology.ppt
100-Mcqs-In-Neonatology.ppt100-Mcqs-In-Neonatology.ppt
100-Mcqs-In-Neonatology.ppt
 
1_4.ppt
1_4.ppt1_4.ppt
1_4.ppt
 
file6162.ppt
file6162.pptfile6162.ppt
file6162.ppt
 

Recently uploaded

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 

Recently uploaded (20)

Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 

D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx

  • 1.
  • 2.
  • 3.
  • 4.  Vasculitides constitute a spectrum of diseases characterized by inflammation & necrosis of blood vessels with resulting ischemia of those tissues supplied by the affected vessels. These are rare diseases & have late diagnosis.
  • 5.  CLASSIFICATION depending on the size of the affected blood vessel:  1- large vessel vasculitis:
  • 6.  -Takayasu's arteritis  - Giant cell arteritis(Polymyalgia rheumatica)  - Aortitis associated with an underlying inflammatory diseases such as spondyloarthropathy
  • 7.  2- medium vessel vasculitis:  - polyarteritis nodosa.  -Churg- Strauss syndrome  - Kawasaki disease
  • 8.  3- small vessel vasculitis :  - Wegener's granulomatosis  - Henoch Schonlein purpura  -Leukocytoclastic vasculitis  -Cryptoglobulinemic vasculitis  -vasculitis associated with connective tissue diseases.
  • 9.  Clinical classification of vasculitis: :  1- purpuric disorders= HSP, leukocytic vasculitis  2- microscopic polyarteritis= polyarteritis nodosa
  • 10.  3- aortic type= Takayosu disease, polyarteritis nodosa(in the latter, the subclavian artery is spared ).  4- pulmonary type= Wegener's granulomatous, Churg- Strauss syndrome
  • 11. GIANT CELL ARTERITIS(GCA)/ POLYMYALGIA RHEUMATICA  GCA also called temporal arteritis or cranial arteritis & this is the most common type of systemic vasculitis.
  • 12. GIANT CELL ARTERITIS(GCA)/ POLYMYALGIA RHEUMATICA  It especially involve branches of carotid artery of patients over the age of 50, often female patients.
  • 13.  C/F : headache not responding to analgesia, scalp tenderness, visual disturbances, jaw claudication, arthralgia& monocular blindness which is irreversible. 90% of patients have high ESR.
  • 14.
  • 15.  Biopsy of a segment of temporal artery; reveals characteristic findings of inflammation & destruction of internal elastic lamina with GIANT cells present.
  • 16. POLYMYALGIA RHEUMATICA(PMR)  Characterized by pain , stiffness of shoulders & hip girdles & proximal extremities. It also associated with high ESR& anemia.  It commonly occurs in female over 50 years.
  • 17.  Diagnosis is made on clinical grounds& rapid response to steroids.  PMR& GCA are likely part of same disease spectrum & some patients may have symptoms of both diseases.
  • 18.  In GCA, corticosteroids treatment is obligatory because they significantly reduce the irreversible visual loss and other focal ischemic lesions, but much higher doses are needed than in PMR.
  • 19.  Treatment should not be delayed, especially if there have already been episodes of visual loss or stroke.
  • 20.   Starting doses of prednisolone are:-  PMR: 10-15 mg as a single dose in the morning.  GCA: 60-100 mg, usually in divided doses.  The dose should be reduced gradually in weekly or monthly steps.
  • 21.  Calcium and vitamin D supplement and sometimes bisphosphonates are necessarily needed to prevent osteoporosis while high dose of steroids are given. In PMR, the response appears in a matter of few days.
  • 22.  The outcome of both disease is excellent , but relapse may occur during treatment or years after cessation of treatment.
  • 23.  TAKAYASU'S ARTERITIS is a large vessel disease that affect young female but can be seen in both male & female up to the age of 50. It also known as pulse less disease.
  • 24.  TA results in stenosis of aorta & its branches like cerebral , brachiocephalic, renal , mesenteric , femoral & coronary arteries.  Stenosis of proximal aorta& its proximal branches is the most common finding.
  • 25.
  • 26.
  • 27.  Clinically limb claudication , lightheadedness, malaise, fever & arthralgia , all are experienced by such patients. There was a delay in diagnosis for years even if the stenosis is sever because most patients are asymptomatic.
  • 28.  Diagnosis is made by angiography. Treatment includes chronic steroids. Some patients may respond to immunosuppressive drugs like methotrexate& cyclophosphamide. Some patients require corrective vascular angioplasty.
  • 29.  POLYARTERITIS NODOSA(PAN) is a medium vessel inflammatory vasculitis involving segmental necrotizing lesions often at arterial branch points leading to stenosis, thrombosis, hemorrhage or infarction of the involved artery.
  • 30.  Classical PAN is rare condition which, unlike other vasculitic diseases, usually occurs in middle- age men. It is accompanied by sever systemic manifestations, and its occasional association with hepatitis B antigenaemia suggest a vasculitis secondary to the deposition of immune complexes.
  • 31.
  • 32.
  • 33.  Pathologically, there is fibrinoid necrosis of vessel walls with microaneurysm formation, thrombosis and infarction.
  • 34. CLINICAL FEATURES::  These include fever, malaise, weight loss and myalgia. These initial symptoms are fallowed by dramatic acute features that are due to organs infarction.
  • 35.  * Neurological features- mononeuritis multiplex  * Abdominal pain due to arterial involvement of abdominal viscera, mimicking acute cholecystitis, pancreatitis and appendicitis.  * Renal- presents with hematuria and proteinuria. Hypertension and acute /chronic renal failure occur.
  • 36.  * Cardiac- Coronary arteritis causes myocardial infarction and heart failure.  * Skin –subcutaneous hemorrhage and gangrene occur.  * Lung involvement is rare.
  • 37. INVESTIGATIONS::  -blood count. Anemia, leukocytosis and high ESR.  * biopsy of involved artery.  -angiography. Demonstrate microaneurysms in hepatic, intestinal or renal vessels.  Most patients are undiagnosed until postoperatively for ischemic events.
  • 38. TREATMENT::-  Corticosteroid usually in combination with immunosuppressive drugs such as azathioprine. The use of antiviral drugs in patients with positive serology of hepatitis B&C is promising.
  • 39.  Churg-Strauss syndrome also known as allergic granulomatosis& agiitis& this is a medium & small vessel vasculitis that has extravascular manifestations which can distinguish it from other types of vasculitis.
  • 40.  The typical presentation is a middle age person with chronic asthma who develops pulmonary infiltrates, vasculitis& eosinophilia. The vasculitis involves the skin, peripheral nerves& GIT, but other organs may be affected.
  • 41.  Biopsy shows microgranulomas& eosinophilic deposits. The pulmonary infiltrates are patchy but rapidly resolve with steroid treatment.  Recent reports showed that anti- leukotriene drugs used in treatment of asthma may cause CSS.
  • 42.  Diagnosis is made depending on clinical findings but biopsy is often needed. Eosinophilia is present in almost all patients but rapidly returns to normal on giving steroids. Anti-neuotrophil cytoplasmic auto antibodies(P- ANCA) are positive in most patients.
  • 43.  Treatment is based on steroids, but immunosuppressive drugs may be needed in some patients. The prognosis is fairly good but relapse rate is common.
  • 44.  WEGENER'S GRANULOMATOSIS(WG)  small& medium vessel vasculitis with many extra vascular manifestations. Although any anatomic area can be affected, the three most common sites of involvement are : the sinuses& upper airways, the lungs, & the kidneys.
  • 45.
  • 46.
  • 47.
  • 48.
  • 50.  The patients may only diagnosed after months or years of subtle symptoms. However WG can be presented with alveolar hemorrhage & or rapidly progressive GN, both of which account for much of the mortality from the disease.
  • 51.  Destruction of nasal sinus tissues may result in facial deformities. Pseudo tumor can occur everywhere but commonly in lungs & retro orbital spaces. Skin , peripheral nerves & eye involvement are common.
  • 52.  Diagnosis is made on tissue biopsy. ANCA of C- ANCA(cytoplasmic) is positive in 90% of patients with renal disease&70% without renal disease. P-ANCA also can be found.  The mortality of untreated WG approaches 100%.
  • 53.  Treatment is steroids, but this is inadequate. Therefore combination with immunosuppressive drugs cyclophosphamide & methotrexate is helpful. Relapse is common.
  • 54. HENOCH SCHONLEIN PURPURA(HSP)  is a small vessel vasculitis affecting children & young adults. Classical clinical triad of palpable purpura at buttocks, arthritis& abdominal pain is found in 80% of patients.
  • 55. HENOCH SCHONLEIN PURPURA(HSP)  Fever & glomerulonephritis are also common. Affected vessels have IG &complement deposition& serum IgA is often elevated. IgA deposition in renal lesions is characteristic. Diagnosis is confirmed depending on clinical & laboratory findings.
  • 56.
  • 57.  Although patients with HSP may develop bowel perforation or significant renal disease, the majority improve without sequelae. Most patients improve within weeks or months.
  • 58.  Ddx: drug induced purpura, SLE, gonococcal arthralgia, keratoderma blennorhagica& secondary syphilis.  Treatment is supportive with NSAIDs & analgesia.  Steroids are kept for more symptomatic patients. Those with chronic renal diseases require steroids & immunosuppressive drugs.  ***********